Alphamab Oncology (9966.HK)

HKD 3.54

(-1.67%)

Eps Summary of Alphamab Oncology

  • Alphamab Oncology's latest annual eps in 2023 was -0.22 CNY , up 37.14% from previous year.
  • Alphamab Oncology's latest quarterly eps in 2024 Q2 was -0.05 CNY , down 0.0% from previous quarter.
  • Alphamab Oncology reported an annual eps of -0.35 CNY in 2022, up 20.45% from previous year.
  • Alphamab Oncology reported an annual eps of -0.44 CNY in 2021, up 4.35% from previous year.
  • Alphamab Oncology reported a quarterly eps of -0.04 CNY for 2023 Q2, down 0.0% from previous quarter.
  • Alphamab Oncology reported a quarterly eps of N/A for 2023 FY, up 37.14% from previous quarter.

Annual Eps Chart of Alphamab Oncology (2023 - 2017)

Historical Annual Eps of Alphamab Oncology (2023 - 2017)

Year Eps Eps Growth
2023 -0.22 CNY 37.14%
2022 -0.35 CNY 20.45%
2021 -0.44 CNY 4.35%
2020 -0.46 CNY 70.51%
2019 -1.56 CNY -817.65%
2018 -0.17 CNY -360.7%
2017 -0.04 CNY 0.0%

Peer Eps Comparison of Alphamab Oncology

Name Eps Eps Difference
Uni-Bio Science Group Limited 0.01 HKD 2081.982%
CK Life Sciences Int'l., (Holdings) Inc. 0.00 HKD 12322.222%